ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Kidney Diseases
Obesity

Diabetes trials near Cincinnati, OH, USA:

Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Cincinnati, Ohio, United States and 35 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Cincinnati, Ohio, United States and 58 other locations

Multi-Center, Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic...

Enrolling
Diabetic Foot Ulcer
Biological: PEP (Purified Exosome Product) / TISSEEL

Phase 2

Rion LLC

Blue Ash, Ohio, United States

it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...

Not yet enrolling
Type 2 Diabetes Mellitus
Drug: LY3209590

Phase 1

Lilly
Lilly

Cincinnati, Ohio, United States and 9 other locations

This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...

Active, not recruiting
Diabetic Macular Edema
Drug: Aflibercept
Drug: Iluvien 0.19 MG Drug Implant

Phase 4

Alimera Sciences

Cincinnati, Ohio, United States and 39 other locations

This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weigh...

Enrolling
Diabetes Mellitus, Type 2
Drug: Trizepatide
Drug: NNC0519-0130

Phase 2

Novo Nordisk
Novo Nordisk

Cincinnati, Ohio, United States and 80 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling
Diabetes Type 2
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Dayton, Ohio, United States and 47 other locations

The main purpose of this study is to determine the safety and efficacy of orforglipron. Participants will have Type 2 Diabetes (T2D) and hav...

Enrolling
Type 2 Diabetes
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Cincinnati, Ohio, United States and 63 other locations

in combination with a basal insulin (i.e., the Rapid-acting Insulin Analog \[RAA\] injection group) in pediatric subjects with type 1 or type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Biological: Rapid-acting Insulin Analog
Biological: Basal Insulin

Phase 3

MannKind
MannKind

Cincinnati, Ohio, United States and 39 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Enrolling
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Cincinnati, Ohio, United States and 103 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems